BiondVax Pharmaceuticals Ltd. BVXV NASDAQ

NASDAQ Capital Marke • Healthcare • Biotechnology • IL • USD

There have been 16 recent insider transactions recorded for BiondVax Pharmaceuticals Ltd. (BVXV), including 0 buys and 16 sells. Total insider buying was valued at RSU Award and total insider selling at $1.76M.

Notable insiders with recent activity include Reichman Amir, Ben-yedidia Tamar, Mark Elad. Insider transactions can provide insights into how company leadership views the stock's valuation and future prospects.

Insider Transactions — BVXV

Date	Name	Role	Transaction	Shares	Avg. Price	Value	Shares Owned
2031-03-02	Reichman Amir	Chief Executive Officer	Disposition	24,000,000	-	-	-
2025-03-23	Ben-yedidia Tamar	Chief Scientist	Disposition	1,500,000	-	-	-
2025-03-23	Mark Elad	Chief Operating Officer	Disposition	1,412,000	-	-	-
2024-10-18	Ben-or Uri	Chief Financial Officer	Disposition	830,000	-	-	-
2023-01-01	Raviv Adi	Director	Disposition	-	-	-	66,800
2023-01-01	Germain Mark	Director	Disposition	6,400,000	$0.17	$1.11M	-
2023-01-01	Laster Morris C	Director	Disposition	-	-	-	66,800
2023-01-01	Margolin Yael	Director	Disposition	-	-	-	66,800
2023-01-01	Rotman Avner	Director	Disposition	-	-	-	66,800
2023-01-01	Lowell George	Director	Disposition	-	-	-	421,680
2023-01-01	Green Jay	Director	Disposition	1,000,000	$0.07	$73K	-
2023-01-01	Moed Samuel J	Director	Disposition	3,280,000	$0.17	$570.72K	-
2023-01-01	Laster Morris C	Director	Disposition	-	-	-	66,800
2023-01-01	Margolin Yael	Director	Disposition	-	-	-	66,800
2023-01-01	Rotman Avner	Director	Disposition	-	-	-	66,800
2023-01-01	Lowell George	Director	Disposition	-	-	-	421,680

■ Informative Buy/Sell — open market transaction (most significant) ■ Uninformative Buy — award, option exercise, conversion ■ Uninformative Sell — tax withholding, award vest sale ■ Neutral — gift, trust, expiry